Driving long-term growth, enabling breakthroughs
Through co-development partnerships, Triple Ring builds ventures that transform innovative technologies into high-value products.
Fill innovation gaps in your two to four-year product pipeline
Flexibility & growth
We offer flexible engagement models that remove barriers to growth.
Co-development partnerships
We support co-investment opportunities, including shared risk and spin-outs, non-dilutive funding, and IP licensing arrangements.
Venture building services
We provide market analysis, tech and IP landscaping, innovation workshops, program design, implementation, incubation facilities, and full-service product development.
Corporate Venture Building Partnership
Triple Ring partners with The Courtney Group & 1540 Ventures
Triple Ring, The Courtney Group, and 1540 Ventures have launched a strategic initiative to fund $5M–$50M corporate spin-out and spin-in programs. This collaboration enables large companies to pursue innovation without immediate financial strain, leveraging deep expertise in venture building, investment, and business development across medtech, life sciences, and related technologies.
The collaboration enables companies to fund 2- to 4-year mid-term projects via balance-sheet-based funding, preserving financial metrics like EPS and EBITDA. Through spin-outs and spin-ins, the program offers a structured way to develop new technologies or reposition non-core assets for external success.
The Power of Partnership
Flexible Structures: Host projects at corporate sites, our labs, or both for autonomy and integration.
Strategic Capital: Unlocking growth capital to fuel innovation, speed commercialization, and reduce risk.
Proven Expertise: Decades of R&D and start-up experience ensure innovation is developed and delivered efficiently.
Acknowledgements
Having worked both in corporate R&D and investment banking, I see the great advantages of funding critical innovation challenges from the balance sheet. I’m excited to be partnered with Triple Ring to enable these important projects.
Ready to discuss corporate venture building?
Partner with us to solve long-term corporate growth challenges:
— Control R&D expenses and maintain EBITDA
— Fill gaps between in-house innovation and M&A
— Assemble focused and dedicated teams
— Secure funding and share risk
— Shorten time-to-market
Bridge the gap between internal innovation and M&A
Triple Ring supports corporate venture building through business strategy, technology development, and product design. This expertise has been built over two decades of launching new businesses and developing breakthrough products.
Speed to market
Helping you accelerate innovation-driven growth at the challenging intersection of technology, biology, and medicine.
Expertise at the ready
End-to-end capabilities, from research and innovation, to design and development, to verification & validation.
Risk sharing & co-development
Flexible engagement models, including venture building as a service or co-development partnerships.
FAQ
Corporate venture building is a strategy to drive innovation by developing new businesses from within large corporations or via external partnerships. Unlike traditional innovation models, corporate venture building integrates entrepreneurial methodologies with corporate resources, allowing companies to rapidly explore and scale new market opportunities without disrupting core operations.
In the rapidly evolving medtech and life-science landscapes, staying competitive requires constant innovation. Yet, balancing core operations with the pursuit of breakthrough technologies can be challenging. Triple Ring offers corporate venture building solutions that allow your company to explore, develop, and scale new opportunities without disrupting existing operations. With two decades of experience and a track record of successful product development, we help your team advance innovation through flexible, venture building engagement models.
Triple Ring supports corporate venture building through its expertise in business strategy, technology development, and product design. Partnering with us means having access to unparalleled expertise in both clinical applications and engineering, ensuring your projects are not only scientifically sound but also market ready. We bring together academic-level intellect with a focused drive to deliver high-quality products.
We offer a range of co-development partnership models, including:
—Skin-in-the-game” product development – Co-development programs including shared-risk contract development and royalty-based IP creation
—Spin-outs and spin-ins – Build-to-buy startup structures with third-party investment and carve-outs to create value from non-core technology
—Non-dilutive funding collaborations – Partnerships to attract funding from agencies including ARPA-H, BARDA, and NIH
We have a deep understanding of the full innovation cycle from concept to market launch. Our proven track record of success accelerating innovation has been created over our 20-year history and 500+ projects. Our staff collectively holds over 300 patents, and we generate new IP for clients routinely. We have earned high satisfaction and retention rates across our client community which includes many of the world’s largest medtech and life science companies, and the brightest startups throughout the world’s healthcare innovation hubs.
It is possible. Together.
Developing new technology is inherently difficult and risky. As a co-development company, we strive to be a trusted partner, not simply a consultant. We structure projects to meet the business needs of our clients, and we often share risk.